Latest filing published 28 Oct 2026 for Shanghai Bao Pharmaceuticals Co., Ltd. - B - H Shares, €45k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +5.6%Entry HK$8.31 · Close 06 Nov 2026 HK$8.78
- +5.8%Entry HK$8.30 · Close 06 Nov 2026 HK$8.78
- -20.2%Entry HK$0.38 · Close at T+90 HK$0.30
- -38.5%Entry HK$0.55 · Close at T+90 HK$0.34
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
劉彥君: trading record in brief
This profile gathers the share dealings of 劉彥君 in Shanghai Bao Pharmaceuticals Co., Ltd. - B - H Shares. In total, 5 filings cover trades dated from 15 May 2026 to 27 October 2026.
Purchases make up the whole of the open-market record (5 purchases, €821k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
A typical purchase (the median) is worth €99k. Scaled by market value, the purchases weigh a median 0.025% of market cap (sample: 3 purchases). Of 5 purchases, 5 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The latest filing, published on 28 October 2026, reports an open-market purchase of €45k in Shanghai Bao Pharmaceuticals Co., Ltd. - B - H Shares. Typically, a trade is published a median of 2 days after it takes place. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Companies and markets linked to 劉彥君
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,700 shares@ HK$7.82610.015% mcap5.5% of flowShareXHKGHKEX:DA20261028E00355Canonical exit: 25 Jan 2027 (T+90)
- 110,500 shares@ HK$7.85810.032% mcap12.0% of flowShareXHKGHKEX:DA20261028E00345Canonical exit: 24 Jan 2027 (T+90)
- 102,100 shares@ HK$7.43580.025% mcap12.7% of flowShareXHKGHKEX:DA20261026E00442Canonical exit: 21 Jan 2027 (T+90)
- 100,000 shares@ HK$16.909532.2% of flowShareXHKGHKEX:DA20260624E00384Canonical exit: 22 Sept 2026 (T+90)
- 150,000 shares@ HK$24.333367.8% of flowShareXHKGHKEX:DA20260518E00041Canonical exit: 13 Aug 2026 (T+90)
5 of 5 declarations